Pure Global
NCT05671237

The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block for Rhinoplasty Operations

The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block on Perioperative Remifentanil Consumption and Postoperative Pain Scores for Rhinoplasty Operations
Istanbul University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anesthesia, Local
Drug/Device/Intervention
bilateral infraorbital+infratrochlear block
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Istanbul University
Location
Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Nov 11, 2022
End date
Mar 01, 2023
Enrollment
60 participants
Primary outcome

Remifentanil consumption

Summary

The aim of our study is to examine the effect of bilateral infraorbital and infratrochlear
 nerve blocks for rhinoplasty operations on perioperative remifentanil need and postoperative
 pain scores.

ICD-10 classifications
Local anaestheticsAnaesthetic, unspecifiedOther and unspecified general anaestheticsPoisoning: Local anaestheticsParenteral anaesthetics
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05671237
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05671237 through Pure Global AI's free database. This phase not specified trial is sponsored by Istanbul University and is currently Recruiting. The study focuses on Anesthesia, Local. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.